
Improved patient experience in mammography

At RSNA 2017 in Chicago, USA, the new MAMMOMAT Revelation1 was presented for the first time.

Seeing the difference can make the difference for a patient
Automated measurement of breast tissue density
Expanding precise diagnosis
Related Links
MAMMOMAT Revelation and Insight BD's current FDA clearance status is 510(k) pending.
The MAMMOMAT Revelation is not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Further details are available from the local Siemens Healthineers organizations.
- The statements by Siemens’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.